About Paul Matthew Carr

This author has not yet filled in any details.
So far Paul Matthew Carr has created 10 blog entries.

Delpor Announces Issuance of US Patent Covering its Novel Implantable Device for the Long-Term Delivery of Antipsychotics and other Drugs

The patent covers Delpor’s PROZORTM technology which enables the sustained release of antipsychotics and other molecules from a matchstick-size implant device. Delpor has several products in development, including a 6-month formulation of risperidone, and a 3-month [...]

By | 2018-01-02T19:55:25+00:00 May 7th, 2017|News|0 Comments

Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device

Delpor has exclusive rights to the patented technology and has several product candidates in development, including 3-6 month formulations of exenatide, liraglutide, and basal insulin. SAN FRANCISCO, CA, April 23, 2015 – Delpor, Inc. (Delpor), [...]

By | 2018-01-02T19:57:24+00:00 April 23rd, 2015|News|0 Comments